MCM
OKUR

MAI Capital Management’s OnKure Therapeutics OKUR Stock Holding History

MAI Capital Management’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6
Closed -$17 – 4503
2025
Q3 		$17 Hold
6
– – ﹤0.01% 3780
2025
Q2 		$15 Hold
6
– – ﹤0.01% 3935
2025
Q1 		$26 Hold
6
– – ﹤0.01% 3404
2024
Q4 		$52 Buy
+6
New +$91 ﹤0.01% 3451
2023
Q4 		– Sell
-12,372
Closed -$942K – 1154
2023
Q3 		$942K Buy
12,372
+5,723
+86% +$389K 0.01% 445
2023
Q2 		$436K Buy
6,649
+1,306
+24% +$105K 0.01% 693
2023
Q1 		$319K Buy
5,343
+2,620
+96% +$94.9K 0.01% 776
2022
Q4 		$63.5K Sell
2,723
-3,598
-57% -$95.4K ﹤0.01% 966
2022
Q3 		$212K Buy
+6,321
New +$208K ﹤0.01% 808

Other funds holding OKUR

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

MAI Capital Management's OKUR Position: Q4 2025 in Review

MAI Capital Management sold out of OnKure Therapeutics (OKUR) in Q4 2025, closing a stake of 6 shares — an estimated $17 sold.

MAI Capital Management first reported a position in OKUR in Q3 2022 and held it in 9 quarters. The position peaked at $942K in Q3 2023. 44 funds tracked by Wall St. Rank hold OKUR as of Q4 2025.

  • MAI Capital Management reported no remaining OnKure Therapeutics position as of Q4 2025 after selling out during the quarter.
  • MAI Capital Management sold 6 OnKure Therapeutics shares in Q4 2025, an estimated $17.
  • MAI Capital Management first reported a position in OnKure Therapeutics in Q3 2022 and held it in 9 quarters.
  • MAI Capital Management's OnKure Therapeutics position peaked at $942K in Q3 2023.
  • 44 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2025.

Based on MAI Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.